أعرض في EDS

The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma

التفاصيل البيبلوغرافية
العنوان: The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma
المؤلفون: Mackay, T.M., Smits, F.J., Roos, D., Bonsing, B.A., Bosscha, K., Busch, O.R., Creemers, G.J., Dam, R.M. van, Eijck, C.H.J. van, Gerhards, M.F., Groot, J.W.B. de, Koerkamp, B.G., Mohammad, N.H., Harst, E. van der, Hingh, I.H.J.T. de, Homs, M.Y.V., Kazemier, G., Liem, M.S.L., Meijer, V.E. de, Molenaar, I.Q., Nieuwenhuijs, V.B., Santvoort, H.C. van, Schelling, G.P. van der, Stommel, M.W.J., Tije, A.J. ten, Vos-Geelen, J. de, Wit, F., Wilmink, J.W., Laarhoven, H.W.M. van, Besselink, M.G., Dutch Pancreatic Canc Grp
المساهمون: Graduate School, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, Surgery, Oncology, CCA - Cancer Treatment and quality of life, Medical Oncology, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: HPB: The official journal of the International Hepato Pancreato Biliary Association, 22(2), 233-240. John Wiley and Sons Inc.
Hpb, 22, 2, pp. 233-240
International Hepato-Pancreato Biliary Association., 22(2), 233. John Wiley and Sons Inc.
HPB, 22(2), 233-240. ELSEVIER SCI LTD
HPB, 22(2), 233-240. John Wiley and Sons Inc.
HPB, 22(2), 233-240. John Wiley & Sons Inc.
Hpb, 22(2), 233-240. ELSEVIER SCI LTD
Mackay, T M, Smits, F J, Roos, D, Bonsing, B A, Bosscha, K, Busch, O R, Creemers, G-J, van Dam, R M, van Eijck, C H J, Gerhards, M F, de Groot, J W B, Groot Koerkamp, B, Haj Mohammad, N, van der Harst, E, de Hingh, I H J T, Homs, M Y V, Kazemier, G, Liem, M S L, de Meijer, V E, Molenaar, I Q, Nieuwenhuijs, V B, van Santvoort, H C, van der Schelling, G P, Stommel, M W J, ten Tije, A J, de Vos-Geelen, J, Wit, F, Wilmink, J W, van Laarhoven, H W M, Besselink, M G & Dutch Pancreatic Cancer Group 2020, ' The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis ', HPB, vol. 22, no. 2, pp. 233-240 . https://doi.org/10.1016/j.hpb.2019.06.019
Hpb, 22, 233-240
بيانات النشر: ELSEVIER SCI LTD, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Male, SURGERY, medicine.medical_treatment, INTERNATIONAL STUDY-GROUP, 030230 surgery, SURGICAL COMPLICATIONS, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Risk Factors, Odds Ratio, Hospital Mortality, POSTOPERATIVE COMPLICATIONS, Netherlands, Gastroenterology, Age Factors, Middle Aged, Pancreaticoduodenectomy, OPEN-LABEL, CANCER, Pancreatic fistula, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, PANCREATICODUODENECTOMY, Female, medicine.drug, Carcinoma, Pancreatic Ductal, medicine.medical_specialty, Hospitals, Low-Volume, 03 medical and health sciences, Pancreatectomy, Pancreatic cancer, medicine, Journal Article, Humans, Aged, Retrospective Studies, Chemotherapy, Performance status, Hepatology, business.industry, MORTALITY, Postoperative complication, Odds ratio, medicine.disease, Gemcitabine, Surgery, Pancreatic Neoplasms, Logistic Models, DEFINITION, GEMCITABINE, Neoplasm Grading, business
الوصف: Contains fulltext : 226028.pdf (Publisher’s version ) (Closed access) BACKGROUND: The relation between type of postoperative complication and not receiving chemotherapy after resection of pancreatic ductal adenocarcinoma (PDAC) is unclear. The aim was to investigate which patient factors and postoperative complications were associated with not receiving adjuvant chemotherapy. METHODS: Patients who underwent resection (2014-2017) for PDAC were identified from the nationwide mandatory Dutch Pancreatic Cancer Audit. The association between patient-, tumor-, center-, treatment characteristics, and the risk of not receiving adjuvant chemotherapy was analyzed with multivariable logistic regression. RESULTS: Overall, of 1306 patients, 24% (n = 312) developed postoperative Clavien Dindo ≥3 complications. In-hospital mortality was 3.5% (n = 46). Some 433 patients (33%) did not receive adjuvant chemotherapy. Independent predictors (all p
وصف الملف: text/plain; application/pdf
اللغة: English
تدمد: 1365-182X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bab622c8bf9a5f70c9a901ded91a0d35
https://doi.org/10.1016/j.hpb.2019.06.019
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....bab622c8bf9a5f70c9a901ded91a0d35
قاعدة البيانات: OpenAIRE
الوصف
تدمد:1365182X